INmune Bio, Inc. Announces First Quarter 2021 Results and Provides Business UpdateGlobeNewsWire • 05/05/21
INmune Bio, Inc. to Report First Quarter 2021 Financial Results and Provide a Corporate Update on Wednesday, May 5GlobeNewsWire • 04/28/21
INmune Bio, Inc. Announces Participation in Fireside Chat at the B Riley Neurosciences ConferenceGlobeNewsWire • 04/26/21
INmune Bio, Inc. Announces Professor Mark Lowdell, PhD, CSO to Deliver Presentations at Two Upcoming Medical MeetingsGlobeNewsWire • 03/22/21
INmune Bio, Inc. (INMB) CEO RJ Tesi on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 03/05/21
INmune Bio, Inc. Announces Fourth Quarter and Full Year 2020 Results and Provides Business UpdateGlobeNewsWire • 03/04/21
INmune Bio, Inc. Announces XPro1595 Found to Decrease Neuroinflammation and Neurodegeneration Biomarkers in Patients with Alzheimer's Disease in Phase 1b TrialGlobeNewsWire • 01/21/21
INmune Bio, Inc. to Host Key Opinion Leader Webinar on Thursday, January 21 at 8 AM ETGlobeNewsWire • 01/13/21
INmune Bio, Inc. Announces First Patient Dosed in Phase 2 Trial of Quellor™ for Pulmonary Complications in COVID-19 PatientsGlobeNewsWire • 11/09/20
INmune Bio, Inc. (INMB) CEO RJ Tesi on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/08/20
INmune Bio, Inc. to Report Third Quarter 2020 Financial Results and Provide a Corporate Update on Thursday, November 5GlobeNewsWire • 10/29/20
INmune Bio, Inc. Presents Preliminary Phase I Data at 21st International Conference on Alzheimer’s Drug DiscoveryGlobeNewsWire • 10/05/20
INmune Bio, Inc. to Host Key Opinion Leader Webinar on Treatment Resistant Depression on Tuesday, September 29GlobeNewsWire • 09/23/20
INmune Bio, Inc. Awarded $2.9 Million NIH Small Business Innovation Research Grant to Support Phase 2 Study of XPro1595 in Patients with Treatment Resistant DepressionGlobeNewsWire • 09/16/20
INmune Bio Inc. (INMB) CEO RJ Tesi on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/09/20
INmune Bio, Inc. Announces Second Quarter 2020 Results and Provides Business UpdateGlobeNewsWire • 08/05/20
INmune Bio, Inc. Schedules Conference Call to Report 2020 Second Quarter Financial ResultsGlobeNewsWire • 07/31/20